Safety, Tolerability & PK of KX2-361 in Subjects w Adv. Malignancies Refractory to Conventional Therapies
Clinical trial NCT02326441 · COMPLETED
Trial details
- NCT number
- NCT02326441
- Sponsor
- Athenex, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-07-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.